High concentrations of H7 human embryonic stem cells at the point of care for acute myocardial infarction

BACKGROUND: Embryonic stem cell (ESC)-derived cardiomyocytes have become one of the most attractive sources of cellular therapy for minimizing heart tissue damage following myocardial infarction (MI). In this study, we investigated the differentiation of BMS-189453-induced H7 human ESCs (hESCs) and...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Yujie, Zhao, Ya, Li, Yang, Yi, Jun, Ma, Yue, Chen, Yundai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7729360/
https://www.ncbi.nlm.nih.gov/pubmed/33313255
http://dx.doi.org/10.21037/atm-20-7230

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7729360/
https://www.ncbi.nlm.nih.gov/pubmed/33313255
http://dx.doi.org/10.21037/atm-20-7230

Ejemplares similares